Literature DB >> 26231995

Current status of corneal xenotransplantation.

Mee Kum Kim1, Hidetaka Hara2.   

Abstract

Corneal allo-transplantation is a well-established technique to treat corneal blindness. However, the limited availability of human donors demands the exploration of alternative treatments such as corneal xenotransplantation (e.g., pigs as donors) and bioengineered corneas. Since the first attempt of corneal xenotransplantation using a donor pig cornea in 1844, great advances have been made in the development of genetically-engineered pigs, effective immunosuppressive protocols and the establishment of guidelines for the conduction of clinical trials. We highlight immunological and physio-anatomical barriers of corneal xenotransplantation, recent progress of corneal xenotransplantation in non-human-primates studies, and regulatory guidelines to conduct clinical trials for corneal xenotransplantation.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical trial; Cornea; Guidelines; Nonhuman primate; Pig; Xenotransplantation

Mesh:

Year:  2015        PMID: 26231995     DOI: 10.1016/j.ijsu.2015.07.685

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  10 in total

1.  Long-term safety outcome of systemic immunosuppression in pig-to-nonhuman primate corneal xenotransplantation.

Authors:  Se Hyun Choi; Chang Ho Yoon; Hyun Ju Lee; Hong Pyo Kim; Jong Min Kim; Jeong-Hwan Che; Kyoung Min Roh; Hyuk Jin Choi; Jiyeon Kim; Eung Soo Hwang; Chung-Gyu Park; Mee Kum Kim
Journal:  Xenotransplantation       Date:  2018-07       Impact factor: 3.907

2.  Effects of gamma radiation sterilization on the structural and biological properties of decellularized corneal xenografts.

Authors:  Mohammad Mirazul Islam; Roholah Sharifi; Shamina Mamodaly; Rakibul Islam; Daniel Nahra; Dina B Abusamra; Pui Chuen Hui; Yashar Adibnia; Mehdi Goulamaly; Eleftherios I Paschalis; Andrea Cruzat; Jing Kong; Per H Nilsson; Pablo Argüeso; Tom Eirik Mollnes; James Chodosh; Claes H Dohlman; Miguel Gonzalez-Andrades
Journal:  Acta Biomater       Date:  2019-07-05       Impact factor: 8.947

Review 3.  Xenotransplantation-the current status and prospects.

Authors:  D K C Cooper; R Gaston; D Eckhoff; J Ladowski; T Yamamoto; L Wang; H Iwase; H Hara; M Tector; A J Tector
Journal:  Br Med Bull       Date:  2018-03-01       Impact factor: 4.291

4.  Development of retrocorneal membrane following pig-to-monkey penetrating keratoplasty.

Authors:  Whayoung Lee; Alex Mammen; Deepinder K Dhaliwal; Cassandra Long; Yuko Miyagawa; David Ayares; David K C Cooper; Hidetaka Hara
Journal:  Xenotransplantation       Date:  2016-11-05       Impact factor: 3.907

5.  Predictive biomarkers for graft rejection in pig-to-non-human primate corneal xenotransplantation.

Authors:  Chang Ho Yoon; Se Hyun Choi; Hyun Ju Lee; Hee Jung Kang; Mee Kum Kim
Journal:  Xenotransplantation       Date:  2019-04-14       Impact factor: 3.907

6.  Anti-CD40 antibody-mediated costimulation blockade promotes long-term survival of deep-lamellar porcine corneal grafts in non-human primates.

Authors:  Jaeyoung Kim; Dong Hyun Kim; Hyuk Jin Choi; Hyun Ju Lee; Hee Jung Kang; Chung-Gyu Park; Eung-Soo Hwang; Mee Kum Kim; Won Ryang Wee
Journal:  Xenotransplantation       Date:  2017-04-10       Impact factor: 3.907

7.  In-situ porcine corneal matrix hydrogel as ocular surface bandage.

Authors:  Ghasem Yazdanpanah; Ritu Shah; Sri Raghurama R Somala; Khandaker N Anwar; Xiang Shen; Seungwon An; Meisam Omidi; Mark I Rosenblatt; Tolou Shokuhfar; Ali R Djalilian
Journal:  Ocul Surf       Date:  2021-04-22       Impact factor: 6.268

8.  Dispersive viscosurgical devices demonstrate greater efficacy in protecting corneal endothelium in vitro.

Authors:  Timur Mert Yildirim; Gerd U Auffarth; Hyeck-Soo Son; Ramin Khoramnia; Donald John Munro; Patrick R Merz
Journal:  BMJ Open Ophthalmol       Date:  2019-02-16

9.  Clinical efficacy of therapeutic keratoplasty using corneal xenografts in patients with corneal ulcers.

Authors:  Mykola Turchyn; Mariya Marushchak; Inna Krynytska; Ivan Klishch
Journal:  Rom J Ophthalmol       Date:  2019 Jul-Sep

Review 10.  Porcine Endogenous Retrovirus (PERV) - Molecular Structure and Replication Strategy in the Context of Retroviral Infection Risk of Human Cells.

Authors:  Krzysztof Łopata; Emilia Wojdas; Roman Nowak; Paweł Łopata; Urszula Mazurek
Journal:  Front Microbiol       Date:  2018-04-11       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.